Inhibrx, Inc. (INBX)
Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function. The company was founded on January 8, 2024 and is headquartered in La Jolla, CA.
Address
11025 N. TORREY PINES ROAD, SUITE 200
LA JOLLA, CA 92037
Founded
2024
Number of Employees
-
Website
http://www.inhibrx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)